https://www.selleckchem.com/
0001). Patients who experienced a complete response to TM-HILP ( = 12) had higher mean levels of MITF and the difference was significant at the time point immediately after the operation (0.29 ± 0.27 vs. 0.06 ± 0.06, = .014) and on postoperative day 1 (1.48 ± 2.24 vs. 0.41 ± 0.65, = .046). There was no association of MITF or S100b levels with 4-year disease specific survival. TM-HILP is associated with increased levels of CMCs, but there was no association of this increase with survival. Patients with complete response to HILP demonstrate higher values o